Cencora, Inc. is a global pharmaceutical sourcing and distribution company focused on improving lives worldwide. It operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. segment distributes brand-name, specialty, and generic pharmaceuticals, over-the-counter products, home healthcare supplies, and related services to healthcare providers like hospitals, pharmacies, and long-term care facilities. The International segment focuses on pharmaceutical wholesale, related services, and global commercialization services. Cencora aims to enhance healthcare delivery for people and animals globally.
When researching a stock like Cencora, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from COR Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for COR stock — the real life supply and demand for the stock over time — and examines that data in different ways. |
26.63
Free COR Email Alerts:
Video: Technical Analysis